Philippe Goupit has a more than 30 year experience of the Pharmaceuticals Industry with more than 20 years spent in Sanofi where he served in different managing positions including Investors Relations, M&A and ultimately as Vice-President Corporate Licenses. Before joining Sanofi, Philippe Goupit started his carrier at Laboratoires Servier and then joined Pasteur Vacccins and Bioprojet.
Philippe Goupit is currently holding two Board Directorships, in Medday a company active in the field of neurodegenerative diseases and in Lysogène an Euronext Paris listed company developping Gene Therapy for rare SNC diseases. Philippe Goupit is graduated from the Faculty of Pharmacy in Paris.
Cutting-Edge Cancer Immunotherapy
60F avenue Rockefeller
69008 Lyon, FRANCE